Cargando…

Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?

Detalles Bibliográficos
Autor principal:	Hanson, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802059/ https://www.ncbi.nlm.nih.gov/pubmed/36777268 http://dx.doi.org/10.1093/crocol/otab005

Ejemplares similares

Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
por: Bernasko, Nana, et al.
Publicado: (2021)

Advancing the science and practice of gastroenterology and hepatology
por: Lim, Joseph K
Publicado: (2015)

Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2019)

Biologics and biosimilars: what, why and how?
por: Chan, Juliana CN, et al.
Publicado: (2017)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Endoscopic advances in gastroenterology
por: Faulx, Ashley L, et al.
Publicado: (2023)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

Advances in Nutrition in Pediatric Gastroenterology
por: Krishnan, Usha, et al.
Publicado: (2023)

Why are biosimilars much more complex than generics?
por: Pagani, Eduardo
Publicado: (2019)

Biosimilars in paediatric inflammatory bowel disease
por: Sieczkowska-Golub, Joanna, et al.
Publicado: (2018)

Advances in cancer immunotherapy for gastroenterological malignancy
por: Kono, Koji
Publicado: (2018)

Many Paradoxes of My Gastroenterology Practice
por: Sonnenberg, Amnon
Publicado: (2021)

Editorial commentary on the Indian Journal of Gastroenterology May-June 2020
por: Limdi, Jimmy K
Publicado: (2020)

Editorial commentary on Indian Journal of Gastroenterology—July–August 2021
por: Limdi, Jimmy K.
Publicado: (2021)

Editorial commentary on Indian Journal of Gastroenterology—September–October 2021
por: Limdi, Jimmy K.
Publicado: (2021)

Editorial commentary on Indian Journal of Gastroenterology—November–December 2021
por: Limdi, Jimmy K.
Publicado: (2022)

Editorial commentary on the Indian Journal of Gastroenterology– May–June 2021
por: Limdi, Jimmy K.
Publicado: (2021)

Editorial commentary on the Indian Journal of Gastroenterology—May–June 2022
por: Limdi, Jimmy K
Publicado: (2022)

Advanced Studies in Clinical and Experimental Research in Gastroenterology
por: Tacheci, Ilja, et al.
Publicado: (2016)

Gastroenterology team members’ knowledge and practices with fertility therapy for women with inflammatory bowel disease
por: Laube, Robyn, et al.
Publicado: (2022)

Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician
por: Moots, Robert, et al.
Publicado: (2017)

Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions
por: Khoo, Thomas, et al.
Publicado: (2022)

New Advances in Gastroenterology: The Crucial Role of Molecular Medicine
por: Candelli, Marcello, et al.
Publicado: (2023)

Imaging in Gastroenterology
por: Badea, Radu, et al.
Publicado: (2014)

Editorial: Reviews in gastroenterology
por: Lan, Tian, et al.
Publicado: (2023)

Current status of biosimilars in the treatment of inflammatory bowel diseases
por: Park, Dong Il
Publicado: (2016)

Insights on the use of biosimilars in the treatment of inflammatory bowel disease
por: Zheng, Michael K, et al.
Publicado: (2017)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology
por: Tinsley, Sara M., et al.
Publicado: (2018)

Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases
por: Pallio, Giovanni
Publicado: (2023)

Biosimilars
por: Martin, Miguel
Publicado: (2018)

Surgical gastroenterology in children
por: Bhatnagar, Veereshwar
Publicado: (2015)

Gastroenterological Cancer and Immunotherapy
por: Wang, Xiaoping, et al.
Publicado: (2018)

Metabonomics in Gastroenterology and Hepatology
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2019)

Nutrition in Pediatric Gastroenterology
por: Romano, Claudio, et al.
Publicado: (2021)

Pediatric Gastroenterology Research
por: Lupu, Vasile Valeriu, et al.
Publicado: (2023)

Telehealth Utilization in Gastroenterology Clinics Amid the COVID-19 Pandemic: Impact on Clinical Practice and Gastroenterology Training
por: Keihanian, Tara, et al.
Publicado: (2020)

The Advance of Gastroenterology
por: Naish, J. M.
Publicado: (1966)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
por: Al Sulais, Eman, et al.
Publicado: (2020)

The European Perspective and History on Biosimilars for the Treatment of Inflammatory Bowel Diseases
por: Solitano, Virginia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k6llfjuvp7iqaajl6tib6rij9n